Particle.news
Download on the App Store

Sudeep Pharma IPO Subscribed 3.41 Times on Day Two as Retail and HNIs Drive Bids

Heavy HNI and retail demand outpaces tepid QIB interest.

Overview

  • BSE data at 1:10 p.m. on Nov. 24 showed overall bids at 3.41 times the offer, with retail at 3.55 times, non-institutional at 7.47 times, and QIBs at 0.11 times.
  • The grey market premium hovered around Rs 120–125 per share, implying roughly a 20–21% upside versus the Rs 593 cap price, though GMP is unofficial and speculative.
  • The Rs 895 crore offer comprises a Rs 95 crore fresh issue and an offer for sale of about 1.35 crore shares worth roughly Rs 800 crore within a price band of Rs 563–593.
  • Bidding closes Nov. 25, share allotment is slated for Nov. 26, refunds and credits are expected Nov. 27, and a tentative listing is set for Nov. 28 on the BSE and NSE.
  • Proceeds are earmarked for machinery procurement at the Nandesari Facility I and for general corporate purposes; ICICI Securities and IIFL Capital Services are lead managers and MUFG Intime India is registrar.